PlainPharmaWatch

CMS Open Payments · Program Year 2024

Skye Orthobiologics LLC

Skye Orthobiologics LLC reported $7,398,584.55 across General Payments, Research, and Ownership to 38 physicians and teaching hospitals across 57 transactions.

See the rankings → How this is sourced
$7.4M
All-tracks total
57
Transactions
38
Recipients
#217
of 1,925 companies

Skye Orthobiologics LLC reported $7,398,584.55 across all CMS Open Payments tracks (General + Research + Ownership) to 38 physicians and teaching hospitals in Program Year 2024 - ranking #217 of 1,925 reporting manufacturers (0.1% of the all-tracks industry total); General Payments alone were $7,207,734.55, averaging $194.7K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer skye-orthobiologics-llc Skye Orthobiologics LLC

$7.4M · #217/1,925 · 0.1% industry · PY2024

  • TOT $7.4M
  • RANK #217
  • SHARE 0.1%
  • TXN 57
  • RCP 38
  • CAT 2
  • GEN $7.2M
  • TOP1 42.8%
  • PY 2024

Volume peers

Nearest volume peer: Straumann USA LLC ($7.6M)

Asklepios Biopharmaceutical …$7.6MDuraStat LLC$7.6MStraumann USA LLC$7.6MSkye Orthobiologics LLC (thi…$7.4MInsulet Corporation$7.2M
All-tracks payment totals near Skye Orthobiologics LLC (CMS Open Payments PY2024)

Skye Orthobiologics LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for Skye Orthobiologics LLC

Skye Orthobiologics LLC ranks #217 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.1% slice of all industry payments reported nationwide for the year. The underlying total is $7,398,584.55 across 57 transactions to 38 physicians and teaching hospitals - $129.8K per transaction and $194.7K per recipient on average.

30 transactions worth $7.2M make "Debt Forgiveness" the top general-payment category in the 2-category breakdown below, 99.8% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 2 types of general payments, Skye Orthobiologics LLC's largest category was "Debt Forgiveness" at $7.2M - 99.8% of General Payments.

How Skye Orthobiologics LLC divides its payments

How the reported total splits across payment categories

1. Debt Forgiveness$7.2M2. Compensation for Services…$12.0K
Payment Type Amount Transactions
Debt Forgiveness $7.2M 30
Compensation for Services Other Than Consulting $12.0K 8

Recipient Concentration in General Payments

The five largest recipient relationships account for $6,234,475.55 (86.5%) of $7,207,734.55 in this company's General Payments records across 36 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Skye Orthobiologics LLC

The five named recipients with the highest reported General Payments from this company

Alexander Frank$3.1MLeah Carrington$1.6MDodie McGee$772.1KAlpesh Desai$573.1KFadi Jaafar$187.8K
  1. 1

    Alexander Frank

    $3,082,225.00 across 1 reported transactions

  2. 2

    Leah Carrington

    $1,619,275.55 across 1 reported transactions

  3. 3

    Dodie McGee

    $772,115.00 across 1 reported transactions

  4. 4

    Alpesh Desai

    $573,060.00 across 1 reported transactions

  5. 5

    Fadi Jaafar

    $187,800.00 across 2 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Skye Orthobiologics LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Skye Orthobiologics LLC.

Aidoc Medical Ltd

HHI 2529

Boehringer Ingelheim RCV GmbH & Co KG

HHI 2525

Oxford Performance Materials, Inc.

HHI 2520

Avirmax Biopharma, Inc

HHI 2519

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Skye Orthobiologics LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Skye Orthobiologics LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.